Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral ...
Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.
Interleukin-23 inhibitors, prior treatment history, and Psoriasis Area and Severity Index scores may be predictive of time to disease relapse among patients with psoriasis who achieved clinical ...
Medicare coverage for biologic therapies -- a mainstay of treatment for rheumatoid arthritis-- has been in flux recently. Medicare Part B coverage for biologic therapy ended in 2004, and the Medicare ...
Please provide your email address to receive an email when new articles are posted on . Biologic therapies are underutilized in non-white populations. By identifying barriers to specific biologic ...
Ustekinumab showed longer drug survival than adalimumab and secukinumab in biologic-naive psoriasis patients in Denmark. Bimekizumab, guselkumab, and risankizumab had lower discontinuation risks in ...
MedPage Today on MSN
Prior biologic use tied to JAK inhibitor benefit in ulcerative colitis
In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...
It is the first clinical trial to evaluate a biologic therapy to prevent serious adverse outcomes in pregnant women with APS and their babies. The study results were published online on April 10, 2025 ...
The Window of Opportunity: Why Early Biologic Use Matters for Patients With Hidradenitis Suppurativa
Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...
News-Medical.Net on MSN
New CHEST guidelines offer evidence-based biologic selection for severe asthma
The American College of Chest Physicians ® (CHEST) recently released a new clinical guideline on biologic management in ...
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
Biologic Therapies has announced it has received FDA clearance for its new bone marrow aspiration catheter, according to a news release. The Bio-MAC bone marrow aspiration catheter is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback